Glaukos outlines $600M–$620M 2026 revenue outlook as Epioxa launch and iDose TR drive growth
Earnings Call Insights: Glaukos Corporation (GKOS) Q3 2025 Management View CEO Thomas Burns began by highlighting "record third quarter consolidated net sales of $133.5 million, up 38% on a reported basis or 37% on a constant currency basis versus the...
Seeking Alpha